De la Torre Canales, G.; Alvarez-Pinzon, N.; Muñoz-Lora, V.R.M.; Vieira Peroni, L.; Farias Gomes, A.; Sánchez-Ayala, A.; Haiter-Neto, F.; Manfredini, D.; Rizzatti-Barbosa, C.M.
Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial. Toxins 2020, 12, 395.
https://doi.org/10.3390/toxins12060395
AMA Style
De la Torre Canales G, Alvarez-Pinzon N, Muñoz-Lora VRM, Vieira Peroni L, Farias Gomes A, Sánchez-Ayala A, Haiter-Neto F, Manfredini D, Rizzatti-Barbosa CM.
Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial. Toxins. 2020; 12(6):395.
https://doi.org/10.3390/toxins12060395
Chicago/Turabian Style
De la Torre Canales, Giancarlo, Natalia Alvarez-Pinzon, Victor Ricardo Manuel Muñoz-Lora, Leonardo Vieira Peroni, Amanda Farias Gomes, Alfonso Sánchez-Ayala, Francisco Haiter-Neto, Daniele Manfredini, and Célia Marisa Rizzatti-Barbosa.
2020. "Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial" Toxins 12, no. 6: 395.
https://doi.org/10.3390/toxins12060395
APA Style
De la Torre Canales, G., Alvarez-Pinzon, N., Muñoz-Lora, V. R. M., Vieira Peroni, L., Farias Gomes, A., Sánchez-Ayala, A., Haiter-Neto, F., Manfredini, D., & Rizzatti-Barbosa, C. M.
(2020). Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial. Toxins, 12(6), 395.
https://doi.org/10.3390/toxins12060395
